Salix Provides Update on FDA Submission for PLENVU®*

February 9, 2018

Responsive image

BRIDGEWATER, N.J., Feb. 9, 2018 /PRNewswire/ — Salix Pharmaceuticals, Ltd. (“Salix”), one of the largest specialty pharmaceutical companies in the world committed to the prevention and treatment of gastrointestinal diseases and a wholly owned subsidiary of Valeant Pharmaceuticals…

Category: Precious Metals